US shuts door on tax inversions | Lex
- 5 years ago
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Lex’s Alan Livsey and Giles Wilkes discuss the decision by the US Treasury to remove the benefit of shifting a company’s tax residence abroad, and how this will affect the recent deal between pharmaceutical companies Allergan and Pfizer.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
Lex’s Alan Livsey and Giles Wilkes discuss the decision by the US Treasury to remove the benefit of shifting a company’s tax residence abroad, and how this will affect the recent deal between pharmaceutical companies Allergan and Pfizer.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes